Pancreatic Cancer Research

ResearcherKurume UniversityActive in the last 2 years

Yusuke Ishida

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9409-6733; OpenAlex author ID A5023439746, A5057917697. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Prospective, multicentre trial on preoperative biliary drainage by endoscopic ultrasound-guided hepaticogastrostomy for resectable/borderline resectable pancre… Co-author DOI 10.1136/bmjopen-2025-106543↗
  2. Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE SIX STUDY. Co-author DOI 10.1111/jgh.16524↗
  3. Standardized Methods Using EUS-guided Fine-needle Biopsy and a Minimal Medium Creates Three Pancreatic Cancer Organoids. Co-author DOI 10.21873/anticanres.15908↗
  4. A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection. Co-author DOI 10.4103/eus.eus_58_17↗
  5. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of th… Co-author DOI 10.1186/s12943-016-0516-4↗
  6. Evaluation of endoscopic cytological diagnosis of unresectable pancreatic cancer prior to and after the introduction of endoscopic ultrasound-guided fine-needl… Co-author DOI 10.3892/mco.2014.277↗
  7. Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice. Co-author DOI 10.1007/s00795-010-0511-6↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susumu Hijioka · 2 shared papers, 2024–2025 · strength 0.36
  2. Daiki Yamashige · 2 shared papers, 2024–2025 · strength 0.36
  3. Shota Harai · 2 shared papers, 2024–2025 · strength 0.36
  4. Takuji Okusaka · 2 shared papers, 2024–2025 · strength 0.36
  5. Jun Ushio · 1 shared paper, 2025 · strength 0.20
  6. Kensuke Kubota · 1 shared paper, 2025 · strength 0.20
  7. Sho Hasegawa · 1 shared paper, 2025 · strength 0.20
  8. Hirotoshi Ishiwatari · 1 shared paper, 2025 · strength 0.20
  9. Shin Yagi · 1 shared paper, 2025 · strength 0.20
  10. Kotaro Takeshita · 1 shared paper, 2025 · strength 0.20
  11. Yusuke Kurita · 1 shared paper, 2025 · strength 0.20
  12. Yoshinobu Okabe · 4 shared papers, 2011–2018 · strength 0.19
  13. Yoshiki Naito · 4 shared papers, 2011–2018 · strength 0.19
  14. Yasuhito Tanaka · 1 shared paper, 2024 · strength 0.16
  15. Hidetoshi Kitamura · 1 shared paper, 2024 · strength 0.16
  16. Masanari Sekine · 1 shared paper, 2024 · strength 0.16
  17. Dai Inoue · 1 shared paper, 2024 · strength 0.16
  18. Reiko Yamada · 1 shared paper, 2024 · strength 0.16
  19. Takeshi Ogura · 1 shared paper, 2024 · strength 0.16
  20. Jun Akiba · 3 shared papers, 2011–2018 · strength 0.15
  21. Fumihito Hirai · 1 shared paper, 2022 · strength 0.13
  22. Yoshihiro Hamada · 1 shared paper, 2022 · strength 0.13
  23. Suguru Hasegawa · 1 shared paper, 2022 · strength 0.13
  24. Tomoyuki Ushijima · 2 shared papers, 2014–2018 · strength 0.12
  25. Takuji Torimura · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.